Goch, Germany

Tobias Schlapp

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Cologne, DE (2003)
  • Köln, DE (2004)
  • Goch, DE (2013 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Tobias Schlapp

Introduction

Tobias Schlapp is a notable inventor based in Goch, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins. With a total of 5 patents to his name, his work has implications for pharmaceutical compositions and viral genome research.

Latest Patents

One of Tobias Schlapp's latest patents focuses on recombinant proteins of parapoxvirus ovis. This invention relates to polynucleotides coding for the PPVO viral genome, including fragments of these polynucleotides and polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also encompasses recombinant proteins expressed from these polynucleotides and their fragments, as well as their use in preparing pharmaceutical compositions.

Career Highlights

Throughout his career, Tobias Schlapp has worked with prominent companies in the biotechnology sector. He has been associated with Aicuris GmbH & Co. KG and Bayer Aktiengesellschaft, where he has contributed to various innovative projects. His expertise in the field has allowed him to make substantial advancements in viral research and protein development.

Collaborations

Tobias has collaborated with several professionals in his field, including Olaf Weber and Angela Siegling. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Tobias Schlapp's work exemplifies the intersection of innovation and biotechnology. His patents and career achievements highlight his commitment to advancing the field and improving pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…